Incidence and management of mycobacterial infection in solid organ transplant recipients

Current Infectious Disease Reports

Volumn 11, Issue 3, 2009, Pages 216-222

  Fan, Ming Hui ^a   Hadjiliadis, Denis ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BCG VACCINE; CALCINEURIN INHIBITOR; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; CYCLOSPORIN A; DOXYCYCLINE; ETHAMBUTOL; IMIPENEM; ISONIAZID; LINEZOLID; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RAPAMYCIN; RIFABUTIN; RIFAMPICIN; RIFAMYCIN DERIVATIVE; STREPTOMYCIN; SULFAMETHOXAZOLE; SULFONAMIDE; TACROLIMUS; TIGECYCLINE; TOBRAMYCIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ANTIBIOTIC SENSITIVITY; ATYPICAL MYCOBACTERIOSIS; BACTERIUM CULTURE; CELLULAR IMMUNITY; CLINICAL FEATURE; DOSE KIDNEY FUNCTION RELATION; DRUG ANTAGONISM; DRUG DOSE INCREASE; DRUG EXCRETION; DRUG METABOLISM; GRAFT RECIPIENT; GRAFT REJECTION; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; MORBIDITY; MORTALITY; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PLEURA BIOPSY; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; TREATMENT DURATION; TUBERCULIN TEST; TUBERCULOSIS;

EID: 65649096592     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-009-0032-4     Document Type: Review

References (49)

1. Rose G: The risk of tuberculosis transmission in solid organ transplantation: Is it more than a theoretical concern? Can J Infect Dis Med Microbiol 2005, 16:304-308.
2. Malone A, McConkey S, Dorman A, et al.: Mycobacterium tuberculosis in a renal transplant transmitted from the donor. Ir J Med Sci 2007, 176:233-235.
3. Winthrop KL, Kubak BM, Pegues DA, et al.: Transmission of mycobacterium tuberculosis via lung transplantation. Am J Transplant 2004, 4:1529-1533.
4. Singh N, Paterson DL: Mycobacterium tuberculosis infection in solid-organ transplant recipients: Impact and implications for management. Clin Infect Dis 1998, 27:1266-1277.
5. Vandermarliere A, Van Audenhove A, Peetermans WE, et al.: Mycobacterial infection after renal transplantation in a Western population. Transpl Infect Dis 2003, 5:9-15.
6. Klote MM, Agodoa LY, Abbott K: Mycobacterium tuberculosis infection incidence in hospitalized renal transplant patients in the United States, 1998-2000. Am J Transplant 2004, 4:1523-1528.
7. Jie T, Matas AJ, Gillingham KJ, et al.: Mycobacterial infections after kidney transplant. Transplant Proc 2005, 37:937-939.
8. Queipo JA, Broseta E, Santos M, et al.: Mycobacterial infection in a series of 1261 renal transplant recipients. Clin Microbiol Infect 2003, 9:518-525.
9. Aguado JM, Herrero JA, Gavalda J, et al.: Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation 1997, 63:1278-1286.
10. Cavusoglu C, Cicek-Saydam C, Karasu Z, et al.: Mycobacterium tuberculosis infection and laboratory diagnosis in solid-organ transplant recipients. Clin Transplant 2002, 16:257-261.
11. Ergun I, Ekmekci Y, Sengul S, et al.: Mycobacterium tuberculosis infection in renal transplant recipients. Transplant Proc 2006, 38:1344-1345.
12. Zhang XF, Lv Y, Xue WJ, et al.: Mycobacterium tuberculosis infection in solid organ transplant recipients: Experience from a single center in China. Transplant Proc 2008, 40:1382-1385.
13. Chen CH, Lian JD, Cheng CH, et al.: Mycobacterium tuberculosis infection following renal transplantation in Taiwan. Transpl Infect Dis 2006, 8:148-156.
14. Hsu MS, Wang JL, Ko WJ, et al.: Clinical features and outcome of tuberculosis in solid organ transplant recipients. Am J Med Sci 2007, 334:106-110.
15. Vachharajani T, Abreo K, Phadke A, et al.: Diagnosis and treatment of tuberculosis in hemodialysis and renal transplant patients. Am J Nephrol 2000, 20:273-277.
16. Kesten S, Chaparro C: Mycobacterial infections in lung transplant recipients. Chest 1999, 115:741-745.
17. Malouf MA, Glanville AR: The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med 1999, 160:1611-1616.
18. Bravo C, Roldan J, Roman A, et al.: Tuberculosis in lung transplant recipients. Transplantation 2005, 79:59-64.
19. Morales P, Briones A, Torres JJ, et al.: Pulmonary tuberculosis in lung and heart-lung transplantation: Fifteen years of experience in a single center in Spain. Transplant Proc 2005, 37:4050-4055.
20. Chan AC, Lo CM, Ng KK, et al.: Implications for management of Mycobacterium tuberculosis infection in adult-to-adult live donor liver transplantation. Liver Int 2007, 27:81-85.
21. Wang B, Lu Y, Yu L, et al.: Diagnosis and treatment for tuberculosis infection in liver transplant recipients: Case reports. Transplant Proc 2007, 39:3509-3511.
22. Munoz P, Palomo J, Munoz R, et al.: Tuberculosis in heart transplant recipients. Clin Infect Dis 1995, 21:398-402.
23. Bossert T, Bittner HB, Richter M, et al.: Successful management of two heart transplant recipients with mycobacterial pulmonary infections. Ann Thorac Surg 2005, 80:719-721.
24. Hsu RB, Fang CT, Chang SC, et al.: Infectious complications after heart transplantation in Chinese recipients. Am J Transplant 2005, 5:2011-2016.
25. Gopi A, Madhavan SM, Sharma SK, et al.: Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 2007, 131:880-889.
26. Losi M, Bossink A, Codecasa L, et al.: Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. Eur Respir J 2007, 30:1173-1179.
27. Liang QL, Shi HZ, Wang K, et al.: Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: A meta-analysis. Respir Med 2008, 102:744-754.
28. Trajman A, Pai M, Dheda K, et al.: Novel tests for diagnosing tuberculous pleural effusion: What works and what does not? Eur Respir J 2008, 31:1098-1106.
29. Patel R, Paya CV: Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997, 10:86-124.
30. Arslan H, Oner-Eyuboglu F, Kalpaklioglu F, et al.: Mycobacterial infections in solid organ transplant recipients. Transplant Proc 1999, 31:3197-3198.
31. Lee J, Yew WW, Wong CF, et al.: Multidrug-resistant tuberculosis in a lung transplant recipient. J Heart Lung Transplant 2003, 22:1168-1173.
32. Saukkonen JJ, Cohn DL, Jasmer RM, et al.: An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006, 174:935-952.
33. Codeluppi M, Cocchi S, Guaraldi G, et al.: Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of Quantiferon TB GOLD results in the transplant setting: A case report. Transplant Proc 2006, 38:1083-1085.
34. Mazurek GH, Zajdowicz MJ, Hankinson AL, et al.: Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays. Clin Infect Dis 2007, 45:826-836.
35. Manuel O, Humar A, Preiksaitis J, et al.: Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007, 7:2797-2801.
36. Griffith DE, Aksamit T, Brown-Elliott BA, et al.: An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
37. Freudenberger RS, Simafranca SM: Cutaneous infection with rapidly-growing mycobacterial infection following heart transplant: A case report and review of the literature. Transplant Proc 2006, 38:1526-1529.
38. Thaunat O, Morelon E, Stern M, et al.: Mycobacterium xenopi pulmonary infection in two renal transplant recipients under sirolimus therapy. Transpl Infect Dis 2004, 6:179-182.
39. Haas S, Scully B, Cohen D, et al.: Mycobacterium avium complex infection in kidney transplant patients. Transpl Infect Dis 2005, 7:75-79.
40. Nagy GS, Rubin RH.: Disseminated Mycobacterium avium-intracellulare in a kidney transplant recipient. Transpl Infect Dis 2001, 3:220-230.
41. Morales P, Ros JA, Blanes M, et al.: Successful recovery after disseminated infection due to Mycobacterium abscessus in a lung transplant patient: Subcutaneous nodule as first manifestation - a case report. Transplant Proc 2007, 39:2413-2415.
42. Todd JL, Lakey J, Howell D, et al.: Portal hypertension and granulomatous liver disease in a lung transplant recipient due to disseminated atypical mycobacterial infection. Am J Transplant 2007, 7:1300-1303.
43. Doucette K, Fishman JA: Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 2004, 38:1428-1439.
44. Fairhurst RM, Kubak BM, Pegues DA, et al.: Mycobacterium haemophilum infections in heart transplant recipients: Case report and review of the literature. Am J Transplant 2002, 2:476-479.
45. LeMense GP, VanBakel AB, Crumbley AJ 3rd, et al.: Mycobacterium scrofulaceum infection presenting as lung nodules in a heart transplant recipient. Chest 1994, 106:1918-1920.
46. Bishburg E, Zucker MJ, Baran DA, et al.: Mycobacterium xenopi infection after heart transplantation: An unreported pathogen. Transplant Proc 2004, 36:2834-2836.
47. Chernenko SM, Humar A, Hutcheon M, et al.: Mycobacterium abscessus infections in lung transplant recipients: The international experience. J Heart Lung Transplant 2006, 25:1447-1455.
48. Wallace RJ Jr, Brown-Elliott BA, Crist CJ, et al.: Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother 2002, 46:3164-3167.
49. Petrini B: MycobactArium abscessus: an emerging rapid-growing potential pathogen. APMIS 2006, 114:319-328.